C WorldWide Group Holding A/S - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 194 filers reported holding HERON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
C WorldWide Group Holding A/S ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$3,354,000
-51.2%
1,202,0690.0%0.04%
-44.0%
Q1 2022$6,876,000
-37.3%
1,202,0690.0%0.08%
-27.9%
Q4 2021$10,975,000
-14.6%
1,202,0690.0%0.10%
-21.2%
Q3 2021$12,850,000
-31.1%
1,202,0690.0%0.13%
-31.2%
Q2 2021$18,656,000
-4.3%
1,202,0690.0%0.19%
+0.5%
Q1 2021$19,486,000
-23.4%
1,202,0690.0%0.19%
-25.1%
Q4 2020$25,442,000
+90.3%
1,202,069
+33.3%
0.26%
+70.0%
Q3 2020$13,369,000
+29.5%
902,069
+28.5%
0.15%
+24.0%
Q2 2020$10,327,000
+25.3%
702,0690.0%0.12%
+5.2%
Q1 2020$8,242,000
-50.0%
702,0690.0%0.12%
-41.6%
Q4 2019$16,499,000
+27.0%
702,0690.0%0.20%
+19.4%
Q3 2019$12,988,000
-0.5%
702,0690.0%0.16%
+1.9%
Q2 2019$13,051,000
+111.8%
702,069
+178.5%
0.16%
+107.7%
Q1 2019$6,161,000
+80.5%
252,069
+91.5%
0.08%
+59.2%
Q4 2018$3,414,000
-39.5%
131,598
-26.2%
0.05%
-31.9%
Q3 2018$5,643,000
-31.2%
178,283
-15.5%
0.07%
-36.8%
Q2 2018$8,198,000
+160.5%
211,012
+85.1%
0.11%
+137.5%
Q1 2018$3,147,000
+32.1%
114,010
-13.4%
0.05%
+41.2%
Q4 2017$2,382,000
+47.5%
131,600
+31.6%
0.03%
+47.8%
Q3 2017$1,615,000100,0000.02%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders